| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 10,710 | 9,727 | 9,321 | | Cost of Revenue | (1,499) | 357 | 1,142 | | | Gross Profit | 12,209 | 9,371 | 8,179 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 3,495 | 1,058 | 420 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 8,713 | 8,313 | 7,759 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,983 | 15,796 | 6,645 | | Earnings Before Interest And Taxes | 21,696 | 24,109 | 14,404 | | Interest Expense | (1,522) | 3,532 | 1,390 | | Income Before Tax | 23,218 | 20,576 | 13,014 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23,218 | 20,576 | 13,014 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 23,218 | 20,576 | 13,014 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,218 | $20,576 | $13,014 |
|
0.31% Nasdaq 
0.05%
Income Statement
